Interpretation of the Updated Clinical Practice Guidelines for Intraductal Papillary Mucinous Neoplasm of the Pancreas(2023 edition)
PU Ning
LIU Liang
LOU Wen-hui
WU Wen-chuan
Abstract：Intraductal papillary mucinous neoplasm(IPMN)of the pancreas is one of the main precursor lesions to pancreatic cancer,and prompt surgical intervention is necessary once malignant transformation is suspected.On July 7,2022,the 26th International Symposium on Pancreatic Diseases was held in Kyoto,Japan,during which a meeting was conducted to discuss further revisions to the diagnosis and treatment guidelines for IPMN,resulting in the formulation of a new edition—Kyoto guidelines.The new edition systematically evaluates evidence collected on five main themes:revision of high-risk stigmata and worrisome features,principles of follow-up for non-surgically resected IPMN,follow-up principles for surgically resected IPMN,revisions in pathology,and research on cyst fluid molecular markers.
Keywords：intraductal papillary mucinous neoplasmguidelinesrisk factoroperative principle
Publication Date：2024-05-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：9( 497-505 )